The Latest Breaking News from ADMA Biologics Inc

Why ADMA Biologics Shares Are Rising Today

ADMA Biologics Inc (NASDAQ: ADMA) shares are trading higher Monday after the company announced it received U.S. Food and Drug Administration approval for its sixth plasma collection center.

Benzinga · Jun 27, 2022

ADMA Biologics' Q4 Top-Line Surpass Estimates, Concludes $175M Debt Refinancing

ADMA Biologics Inc (NASDAQ: ADMA) closed a debt refinancing with Hayfin Capital Management of $150 million, and up to an additional $25 million tied to specific revenue targets during 2022.

Benzinga · Mar 25, 2022

ADMA Biologics Shares Gain As Interim Q4 Sales Beat Expectation

ADMA Biologics Inc (NASDAQ: ADMA) expects 

Benzinga · Jan 19, 2022